The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 12, 2026

Filed:

Jul. 01, 2019
Applicant:

Fresenius Kabi Deutschland Gmbh, Bad Homburg, DE;

Inventors:

Melanie Denkinger, Oberursel, DE;

Ewald Schlotzer, Bad Homburg, DE;

Edmundo Brito De La Fuente, Bad Homburg, DE;

Lida A. Quinchia-Bustamante, Friedberg, DE;

Crispulo Gallegos-Montes, Bad Homburg, DE;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 31/14 (2006.01); A61K 31/197 (2006.01); A61K 31/202 (2006.01); A61K 31/355 (2006.01); A61K 31/575 (2006.01); A61K 35/60 (2006.01); A61K 36/06 (2006.01); A61K 36/48 (2006.01); A61K 36/63 (2006.01); A61P 1/16 (2006.01); A61P 29/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0029 (2013.01); A61K 9/107 (2013.01); A61K 31/14 (2013.01); A61K 31/197 (2013.01); A61K 31/202 (2013.01); A61K 31/355 (2013.01); A61K 31/575 (2013.01); A61K 35/60 (2013.01); A61K 36/06 (2013.01); A61K 36/48 (2013.01); A61K 36/63 (2013.01); A61P 1/16 (2018.01); A61P 29/00 (2018.01);
Abstract

The present disclosure relates to lipid emulsions for parenteral administration, comprising 10 to 30% of a lipid phase comprising soybean oil, medium-chain triglycerides (MCT), olive oil and fish oil and less than 25 mg, preferably less than 20 mg, campesterol, less than 30 mg, preferably less than 25 mg, stigmasterol and less than 120 mg, preferably less than 100 mg, betasitosterol per 100 g of the lipid phase. The present disclosure also relates to the lipid emulsions according to the present disclosure for providing parenteral nutrition, in particular to neonates, as well as to methods for manufacturing the lipid emulsions according to the present disclosure.


Find Patent Forward Citations

Loading…